U2Bio Co., Ltd. (KOSDAQ:221800)
3,245.00
+75.00 (2.37%)
At close: Sep 19, 2025
U2Bio Market Cap
U2Bio has a market cap or net worth of 36.57 billion as of September 19, 2025. Its market cap has decreased by -18.49% in one year.
Market Cap
36.57B
Enterprise Value
3.16B
Revenue
25.15B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,245.00
Market Cap Chart
Since April 3, 2017, U2Bio's market cap has increased from 28.86B to 36.57B, an increase of 26.74%. That is a compound annual growth rate of 2.84%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 19, 2025 | 36.57B | 21.58% |
Dec 30, 2024 | 30.08B | -49.53% |
Dec 28, 2023 | 59.60B | 20.84% |
Dec 29, 2022 | 49.32B | -12.03% |
Dec 30, 2021 | 56.07B | 276.76% |
Dec 30, 2020 | 14.88B | -39.54% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Apr 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 510.39T |
SK hynix | 230.25T |
LG Energy Solution | 81.90T |
Samsung Biologics | 72.60T |
Hanwha Aerospace | 52.99T |
Hyundai Motor Company | 47.21T |
HD Hyundai Heavy Industries | 44.92T |
KB Financial Group | 43.08T |